First Trust Advisors LP Abb Vie Inc. Transaction History

First Trust Advisors LP

$95.8 Billion
Q1 2024

A detailed history of First Trust Advisors LP transactions in Abb Vie Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 3,348,832 shares of ABBV stock, worth $574 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

3,348,832

Previous 3,872,452 13.52%

Holding current value

$574 Million

Previous $600 Million 1.62%

% of portfolio

0.64%

Previous 0.67%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $83.7 Million - $95.4 Million	-523,620 Reduced 13.52%	3,348,832 $610 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $29.4 Million - $33.1 Million	-213,358 Reduced 5.22%	3,872,452 $600 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $50.3 Million - $58.2 Million	-376,411 Reduced 8.44%	4,085,810 $609 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $15.5 Million - $19.3 Million	-117,224 Reduced 2.56%	4,462,221 $601 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $112 Million - $129 Million	777,433 Added 20.45%	4,579,445 $730 Million

Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $94.9 Million - $114 Million	686,191 Added 22.02%	3,802,012 $615 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $15.8 Million - $18.2 Million	117,912 Added 3.93%	3,115,821 $418 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $202 Million - $256 Million	1,465,720 Added 95.66%	2,997,909 $459 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $70 Million - $86.8 Million	530,127 Added 52.9%	1,532,189 $248 Million
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $11.2 Million - $14.2 Million	-104,706 Reduced 9.46%	1,002,062 $136 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $8.59 Million - $9.75 Million	-80,730 Reduced 6.8%	1,106,768 $119 Million
Q2 2021 Oct 12, 2021	SELL	$105.21 - $117.21 $8.59 Million - $9.57 Million	-81,672 Reduced 6.44%	1,187,498 $134 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $18.2 Million - $20.3 Million	-172,909 Reduced 11.99%	1,269,170 $143 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $38.2 Million - $42.1 Million	373,635 Added 34.97%	1,442,079 $156 Million
Q4 2020 Feb 02, 2021	SELL	$80.49 - $108.67 $22.8 Million - $30.7 Million	-282,758 Reduced 20.93%	1,068,444 $114 Million
Q3 2020 Nov 05, 2020	SELL	$85.91 - $100.83 $36.2 Million - $42.5 Million	-421,306 Reduced 23.77%	1,351,202 $118 Million
Q2 2020 Jul 22, 2020	BUY	$73.37 - $98.18 $51.3 Million - $68.7 Million	699,303 Added 65.16%	1,772,508 $174 Million
Q1 2020 May 06, 2020	SELL	$64.5 - $97.79 $432,408 - $655,584	-6,704 Reduced 0.62%	1,073,205 $81.8 Million
Q4 2019 Feb 03, 2020	SELL	$72.13 - $90.25 $8.66 Million - $10.8 Million	-120,045 Reduced 10.0%	1,079,909 $95.6 Million
Q3 2019 Nov 04, 2019	BUY	$62.98 - $75.72 $10 Million - $12 Million	158,805 Added 15.25%	1,199,954 $90.9 Million
Q2 2019 Jul 30, 2019	SELL	$65.7 - $83.98 $21.7 Million - $27.8 Million	-330,828 Reduced 24.11%	1,041,149 $75.7 Million
Q1 2019 May 09, 2019	BUY	$77.14 - $90.79 $51.7 Million - $60.8 Million	670,186 Added 95.5%	1,371,977 $111 Million
Q4 2018 Feb 07, 2019	SELL	$77.85 - $96.01 $38.2 Million - $47.1 Million	-490,174 Reduced 41.12%	701,791 $64.7 Million
Q3 2018 Oct 25, 2018	SELL	$88.91 - $98.84 $13.4 Million - $14.8 Million	-150,164 Reduced 11.19%	1,191,965 $113 Million
Q2 2018 Aug 02, 2018	BUY	$89.78 - $106.23 $31.1 Million - $36.8 Million	346,459 Added 34.8%	1,342,129 $124 Million
Q1 2018 Apr 23, 2018	SELL	$92.01 - $123.21 $20 Million - $26.8 Million	-217,183 Reduced 17.91%	995,670 $94.2 Million
Q4 2017 Feb 08, 2018	SELL	$89.56 - $98.21 $7.7 Million - $8.44 Million	-85,957 Reduced 6.62%	1,212,853 $117 Million
Q3 2017 Oct 24, 2017	BUY	$69.85 - $89.22 $90.7 Million - $116 Million	1,298,810	1,298,810 $115 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Abb Vie Inc. Transaction History